Ambovex(®) as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial

Hepatocellular carcinoma (HCC) is a global public health problem, based on it being the fifth most common cancer and third leading cause of cancer-related mortality worldwide. The approved conventional treatment methods for HCC have shown life-threatening side effects with limited or negligible succ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Hepatocell Carcinoma
Hauptverfasser: Salama, Hosny, Ahmad, Hassan, Elchagea, Ismail, Zekri, Abdel Rahman, Medhat, Eman, Bahnassy, Abeer, Lange, Michael, Rabbat, Mohammed, de la Torre, Andrew N, Punamiya, Pravin
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2015
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4918287/
https://ncbi.nlm.nih.gov/pubmed/27508197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S60864
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge